Κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake

Journal of Neuroscience

Volumn 35, Issue 10, 2015, Pages 4296-4305

  Whitfield, Timothy W ^a   Schlosburg, Joel E ^a   Wee, Sunmee ^b   Gould, Adam ^a   George, Olivier ^a   Grant, Yanabel ^a   Zamora Martinez, Eva R ^a   Edwards, Scott ^c   Crawford, Elena ^a   Vendruscolo, Leandro F ^a,d   Koob, George F ^a,e  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Dynorphin; Escalation; Kappa opioid receptors; Methamphetamine; Nucleus accumbens; Substances of abuse

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR; METHAMPHETAMINE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; PRODYNORPHIN; CENTRAL STIMULANT AGENT; ENKEPHALIN; NALTREXONE; NARCOTIC ANTAGONIST; PREPROENKEPHALIN; PROTEIN PRECURSOR;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR COMMISSURE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG SELF ADMINISTRATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; OPTICAL DENSITY; POST HOC ANALYSIS; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANCE ABUSE; UPREGULATION; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; METABOLISM; REINFORCEMENT; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; ENKEPHALINS; MALE; METHAMPHETAMINE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 84924439937     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1978-13.2015     Document Type: Article

References (61)

1. Adams DH, Hanson GR, Keefe KA (2003) Distinct effects of methamphet-amine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix. J Neurochem 84:87–93.
2. Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298–300.
3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, IV-TR. Washington, DC: American Psychiatric Press.
4. Bruchas MR, Chavkin C (2010) Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210:137–147.
5. Bruchas MR, Macey TA, Lowe JD, Chavkin C (2006) Kappa opioid receptor activationofp38 MAPKisGRK3- and arrestin-dependent inneurons and astrocytes. J Biol Chem 281:18081–18089.
6. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272–2275.
7. Chartoff EH, Carlezon WA Jr (2014) Drug withdrawal conceptualized as a stressor. Behav Pharmacol 25:473–492.
8. Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA (2012)Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuro-pharmacology 62:167–176.
9. Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215:413–415.
10. Cole RL, Konradi C, Douglass J, Hyman SE (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813–823.
11. Daunais JB, Roberts DC, McGinty JF (1993) Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neu-roreport 4:543–546.
12. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E (1999) Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 877:461–485.
13. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681: 147–152.
14. Gray AM, Rawls SM, Shippenberg TS, McGinty JF (1999) The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J Neurochem 73:1066–1074.
15. Hadamitzky M, Markou A, Kuczenski R (2011) Extended access to meth-amphetamine self-administration affects sensorimotor gating in rats. Be-hav Brain Res 217:386–390.
16. Horan P, Taylor J, Yamamura HI, Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237–1243.
17. Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992) Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res 13:165–170.
18. Hyman SE, Cole RL, Konradi C, Kosofsky BE (1995) Dopamine regulation of transcription factor-target interactions in rat striatum. Chem Senses 20:257–260.
19. Ito R, Robbins TW, Everitt BJ (2004) Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci 7:389–397.
20. Jang CG, Whitfield T, Schulteis G, Koob GF, Wee S (2013) A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats. Psychopharmacology (Berl) 225:753–763.
21. Jones DN, Holtzman SG (1992) Long term kappa-opoid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 215:345–348.
22. Kitamura O, Wee S, Specio SE, Koob GF, Pulvirenti L (2006) Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) 186:48–53.
23. Knoll AT, Calezon WA Jr(2010) Dynorphin, stress, and depression. Brain Res 1314:56–73.
24. Knoll JH, Lichter P, Bakdounes K, Eltoum IE (2007) In situ hybridization and detection using nonisotopic probes. Curr Protoc Mol Biol 14:147.
25. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723.
26. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97–129.
27. Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW Jr, George O (2014) Addiction as a stress surfeit disorder. Neuropharmacology 76:370–382.
28. Larson EB, Graham DL, Arzaga RR, Buzin N, Webb J, Green TA, Bass CE, Neve RL, Terwilliger EF, Nestler EJ, Self DW (2011) Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats. J Neurosci 31:16447–16457.
29. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, CarlezonWA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323–330.
30. Mandyam CD, Wee S, Crawford EF, Eisch AJ, Richardson HN, Koob GF (2008) Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis. Biol Psychiatry 64:958–965.
31. Meshul CK, McGinty JF (2000) Kappa opioid receptor immunoreactivity in nucleus accumbens shell and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96:91–99.
32. Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86:274–280.
33. Nealey KA, Smith AW, Davis SM, Smith DG, Walker BM (2011) Kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology 61:35–42.
34. Nestler EJ (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47:24–32.
35. Orio L, Wee S, Newman AH, Pulvirenti L, Koob GF (2010) The dopamine D3 receptor partial agonist CJB090 and antagonist PG 01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict Biol 15:312–323.
36. Parsegian A, Glen WB Jr, Lavin A, See RE (2011) Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry 69:253–259.
37. Paxinos G, Watson C (2006) The rat brain in sterotaxic coordinates. San Diego: Academic.
38. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesismediated by kappa opiate receptors. Science 233:774–776.
39. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397-7403.
40. Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH (2011) Repeated exposure to the K-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry 70:744–753.
41. Reichel CM, Schwendt M, McGinty JF, Olive MF, See RE (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36:782-792.
42. Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing effi-ciacy. J Neurosci Methods 66:1–11.
43. Roberts DC, Koob Gf, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781–787.
44. Rocha A, Kalivas PW (2010) Role of the prefrontal cortex and nucleus accumbens in reinstating methamphetamine seeking. Eur J Neurosci 31: 903–909.
45. Rogers JL, De Santis S, See RE (2008) Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) 199:615–624.
46. Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl) 144:339–346.
47. Schindler Ag, Messinger DI, Smith JS, Shankar H, Gustin RM, Schattauer SS, Lemos JC, Chavkin NW, Hagan CE, Neumaier JF, Chavkin C (2012) Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 32:17582–17596.
48. Schlosburg JE, Whitfield TW Jr, Park PE, Crawford EF, George O, Vendr-uscolo LF, Koob GF (2013) Long-term antagonism of k opioid receptors prevents escalation of and increased motivation for heroin intake. J Neurosci 33:19384–19392.
49. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kalivas PW (2009) Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331:555.562.
50. Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the pathophys-iology of drug addiction. Pharmacol Ther 116:306–321.
51. Simpson JN, McGinty JF (1995) Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse 19:151–159.
52. Smith AJ, McGinty JF (1994) Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Brain Res Mol Brain Res 21:359–362.
53. Todtenkopf MS, Marcus JF, Portoghese PS, Carlezoh WA Jr (2004) Effects of K-opioid receptor ligands on intracranial self-stimulation in rats. Psycho-pharmacology (Berl) 172:463–470.
54. Svingos AL, Colago EE, Pickel VM (1999) Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J Neurosci 19:1804–1813.
55. Walker BM, Zorilla EP, Koob GF (2011) Systemic K-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 16:116–119.
56. Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A (1982) Compar-ison of the distribution of dynorphin systems and enkephalin systems in brain. Science 218:1134–1136.
57. Wee S, Koob GF (2010) The role of the dynorphin-KOR opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121– 135.
58. Wee S, Wang Z, Woolverton WL, Pulvirenti L, Koob GF (2007) Effect of aripiprazole, a partial D2 receptor agonist, on increased rate of metham-phetamine self-administration in rats with prolonged access. Neuropsy-chopharmacology 32:2238–2247.
59. Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF (2009) Inhibitionofkappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology 205:565–575.
60. Willuhn I, Burgeno LM, Groblewski PA, Phillips PE (2014) Excessive cocaine use results from decreased phasic dopamine signaling in the stria-tum. Nat Neurosci 17:704–709.
61. Zhou Y, Leri F, Grella SL, Aldrich JV, Kreek MJ (2013) Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats. Synapse 67:358–361.